Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
Document Type
Journal Article
Publication Date
8-22-2017
Journal
Annals of Internal Medicine
DOI
10.7326/M17-0520
APA Citation
Gulick, R., Wilkin, T., Chen, Y., Landovitz, R., Amico, K., Young, A., Richardson, P., Marzinke, M., Hendrix, C., Eshleman, S., McGowan, I., Cottle, L., Andrade, A., Marcus, C., Klingman, K., Chege, W., Rinehart, A., Rooney, J., Andrew, P., Salata, R., Siegel, M., Manabe, Y., Frank, I., Ho, K., Santana, J., Stekler, J., Swaminathan, S., McCauley, M., Hodder, S., & Mayer, K. (2017). Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.. Annals of Internal Medicine, (). http://dx.doi.org/10.7326/M17-0520
Peer Reviewed
1
